The global flea, tick, and heartworm products market deals with various drugs and medicines used to prevent and treat illnesses caused by flea, ticks, and heartworms in pets. These products are available in the form of spot-ons, collars, shampoos, powders, and oral tablets.
The Global Flea, Tick, and Heartworm Products Market is estimated to be valued at US$ 3.14 Bn in 2024 and is expected to exhibit a CAGR of 8.5% over the forecast period 2024 to 2031. Increased pet adoption and rising awareness about pet healthcare are majorly driving the growth of this market.
Key Takeaways
Key players operating in the flea, tick, and heartworm products market are Zoetis, Promika, LLC, Sergeant’s Pet Care Products, Inc., Adams, Merck and Co., Inc., Boehringer Ingelheim International GmbH, Virbac, Inc., Elanco, Ceva, and The Hartz Mountain Corporation. Zoetis dominates the global market with its broad portfolio of oral and topical products for flea, tick, and heartworm prevention and treatment.
The growing Global Flea, Tick, and Heartworm Products Market Demand is attributable to factors such as rising pet adoption, increasing per capita pet healthcare expenditure, and growing awareness about zoonotic diseases transmitted by parasites. According to recent estimates, over 85 million American households own a pet, with 64.2 million owning dogs and 42.7 million owning cats.
Geographically, North America represents the largest market for flea, tick, and heartworm products owing to high pet ownership, severe flea and tick infestation problems, and robust awareness about pet healthcare. However, Asia Pacific is expected to witness the fastest growth during the forecast period driven by factors such as rising middle-class incomes, growing millennial population, and increasing trend of nuclear families keeping pets for companionship.
Gets More Insights on: Global Flea, Tick, and Heartworm Products Market
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian